Scott Requadt - Net Worth and Insider Trading
Scott Requadt Net Worth
The estimated net worth of Scott Requadt is at least $260,698 dollars as of 2024-06-06. Scott Requadt is the CEO of Talaris Therapeutics Inc and owns about 95,845 shares of Talaris Therapeutics Inc (TALS) stock worth over $260,698. Details can be seen in Scott Requadt's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott Requadt has not made any transactions after 2022-07-29 and currently still holds the listed stock(s).
Transaction Summary of Scott Requadt
Scott Requadt Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Requadt owns 6 companies in total, including ESSA Pharma Inc (EPIX) , VBI Vaccines Inc (VBIV) , and Entasis Therapeutics Holdings Inc (ETTX) among others .
Click here to see the complete history of Scott Requadt’s form 4 insider trades.
Insider Ownership Summary of Scott Requadt
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EPIX | ESSA Pharma Inc | 2020-10-01 | director |
| VBIV | VBI Vaccines Inc | 2016-12-31 | director |
| ETTX | Entasis Therapeutics Holdings Inc | 2018-09-25 | 10 percent owner |
 | | 2018-07-02 | 10 percent owner |
| | 2018-06-20 | director |
| | 2022-07-29 | director & See Remarks |
Scott Requadt Latest Holdings Summary
Scott Requadt currently owns a total of 1 stock. Scott Requadt owns 95,845 shares of Talaris Therapeutics Inc (TALS) as of July 29, 2022, with a value of $260,698.
Latest Holdings of Scott Requadt
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TALS | Talaris Therapeutics Inc | 2022-07-29 | 95,845 | 2.72 | 260,698 |
Holding Weightings of Scott Requadt
Scott Requadt Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Requadt has made a total of 3 transactions in Talaris Therapeutics Inc (TALS) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Talaris Therapeutics Inc is the acquisition of 3,938 shares on July 29, 2022, which cost Scott Requadt around $167,374.
Insider Trading History of Scott Requadt
- 1
Scott Requadt Trading Performance
GuruFocus tracks the stock performance after each of Scott Requadt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott Requadt is -63.55%. GuruFocus also compares Scott Requadt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott Requadt within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Scott Requadt's insider trading performs compared to the benchmark.
Performance of Scott Requadt
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.55 | | | | | |
| Relative Return to S&P 500(%) | -14.11 | | | | | |
Scott Requadt Ownership Network
Scott Requadt Owned Company Details
What does ESSA Pharma Inc do?
Who are the key executives at ESSA Pharma Inc?
Scott Requadt is the director of ESSA Pharma Inc. Other key executives at ESSA Pharma Inc include Chief Operating Officer Peter Virsik , director & Chief Executive Officer David Ross Parkinson , and Chief Financial Officer David S. Wood .
ESSA Pharma Inc (EPIX) Insider Trades Summary
Over the past 18 months, Scott Requadt made no insider transaction in ESSA Pharma Inc (EPIX). Other recent insider transactions involving ESSA Pharma Inc (EPIX) include a net sale of 78,475 shares made by Peter Virsik , a net purchase of 99,730 shares made by Franklin M Berger , and a net purchase of 33,657 shares made by David Ross Parkinson .
In summary, during the past 3 months, insiders sold 1,388 shares of ESSA Pharma Inc (EPIX) in total and bought 0 shares, with a net sale of 1,388 shares. During the past 18 months, 78,475 shares of ESSA Pharma Inc (EPIX) were sold and 133,387 shares were bought by its insiders, resulting in a net purchase of 54,912 shares.
ESSA Pharma Inc (EPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
ESSA Pharma Inc Insider Transactions
Scott Requadt Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Requadt. You might contact Scott Requadt via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
